Document Detail


Serum retinoids in retinitis pigmentosa patients treated with vitamin A.
MedLine Citation:
PMID:  8871145     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Patients with retinitis pigmentosa have been suggested to benefit from treatment with moderate doses of retinyl palmitate. Retinyl palmitate is not an active retinoid in itself but is metabolised to active components in the body. To find out which metabolites of retinyl palmitate were formed and at which concentrations, we measured the concentrations of retinol, retinyl palmitate, retinoic acids and tocopherol in serum of patients treated with oral retinyl palmitate for retinitis pigmentosa. METHODS: Nine male patients and one female diagnosed as having retinitis pigmentosa after a complete ophthalmological examination including a full-field electroretinogram were given vitamin A at their own request as one daily morning dose of 16600 IU vitamin A. Blood samples were obtained before and after > 2 weeks of treatment. The concentrations of retinoids and tocopherol were measured with established methods. RESULTS: The patients were not deficient in vitamin A or vitamin E as judged from the serum vitamin concentrations. Treatment with retinyl palmitate significantly increased the serum concentration of retinyl palmitate and of 13-cis-retinoic acid but not of retinol, tocopherol or all-trans-retinoic acid. CONCLUSIONS: Neither retinyl palmitate nor 13-cis-retinoic acid, are known to be biologically active. However, 13-cis-retinoic acid can isomerise to the active vitamin A derivative, all-trans-retinoic acid. It is suggested that patients may be treated with a small dose of 13-cis-retinoic acid instead, to avoid the relatively long metabolic detour from retinyl palmitate.
Authors:
G A Fex; S Andréasson; B Ehinger
Related Documents :
7729565 - Anti-retinoic acid monoclonal antibody localizes all-trans-retinoic acid in target cell...
17438145 - Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis.
1760155 - In vitro formation of retinoic acid from retinal in rat liver.
1647645 - Antioxidant effect of retinoic acid on pc12 rat pheochromocytoma.
16826375 - Variations in the energy metabolism of biotechnologically relevant heterofermentative l...
2173015 - The induction of lipid peroxidation in liposomal membrane by ultrasound and the role of...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie     Volume:  234 Suppl 1     ISSN:  0721-832X     ISO Abbreviation:  Graefes Arch. Clin. Exp. Ophthalmol.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  1997-01-16     Completed Date:  1997-01-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8205248     Medline TA:  Graefes Arch Clin Exp Ophthalmol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  S18-21     Citation Subset:  IM    
Affiliation:
Department of Clinical Chemistry, Lund University Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Aged
Anticarcinogenic Agents / blood
Chromatography, High Pressure Liquid
Electroretinography
Female
Humans
Male
Middle Aged
Retinitis Pigmentosa / blood*,  drug therapy,  physiopathology
Retinoids / blood*
Tretinoin / analogs & derivatives,  blood
Vitamin A / analogs & derivatives,  blood,  therapeutic use*
Vitamin E / blood
Chemical
Reg. No./Substance:
0/Anticarcinogenic Agents; 0/Retinoids; 11103-57-4/Vitamin A; 1406-18-4/Vitamin E; 302-79-4/Tretinoin; 38030-57-8/4-oxoretinoic acid; 79-81-2/retinol palmitate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of individual microaneurysms: a comparison between fluorescein angiograms and red-fre...
Next Document:  Adenocarcinoma of the retinal pigment epithelium: a diagnostic and therapeutic challenge.